PERRIGO CO

Delisted

CIK 820096fmd_1V5NZY9RH8BH9WM4CD924SKMT5Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jun 29, 2008 to Dec 29, 2013, 19 periods

Income Statement · Annual · Millions · USD
Line item	FY2009	FY2010	FY2011	FY2012	FY2013
Total revenues	2,006	2,268	2,755	3,173	3,540
Cost of revenue	1,408	1,522	1,810	2,078	2,260
Gross profit	597	746	945	1,096	1,280
Research and development	77	84	89	106	115
Selling, general and administrative	232	270	330	373	426
Total operating expenses	333	382	454	518	–
Operating income	249	336	490	569	679
Other non-operating income (expense)	(1)	1	3	4	(1)
Income before taxes	206	309	451	512	608
Income tax expense	63	84	110	119	166
Net income from continuing operations	143	224	341	393	442
Net income	146	224	339	402	442